Cargando…
Neurodevelopment and early pharmacological interventions in Fragile X Syndrome
Fragile X Syndrome (FXS) is a neurodevelopmental disorder and the leading monogenic cause of autism and intellectual disability. For years, several efforts have been made to develop an effective therapeutic approach to phenotypically rescue patients from the disorder, with some even advancing to lat...
Autores principales: | Milla, Luis A., Corral, Lucia, Rivera, Jhanpool, Zuñiga, Nolberto, Pino, Gabriela, Nunez-Parra, Alexia, Cea-Del Rio, Christian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433175/ https://www.ncbi.nlm.nih.gov/pubmed/37599992 http://dx.doi.org/10.3389/fnins.2023.1213410 |
Ejemplares similares
-
Structural and Functional Abnormalities in the Olfactory System of Fragile X Syndrome Models
por: Bodaleo, Felipe, et al.
Publicado: (2019) -
Disrupted inhibitory plasticity and homeostasis in Fragile X syndrome
por: Cea-Del Rio, C.A., et al.
Publicado: (2020) -
The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome
por: Cea-Del Rio, Christian A., et al.
Publicado: (2014) -
The Basal Forebrain Modulates Neuronal Response in an Active Olfactory Discrimination Task
por: Nunez-Parra, Alexia, et al.
Publicado: (2020) -
Emerging pharmacologic treatment options for fragile X syndrome
por: Schaefer, Tori L, et al.
Publicado: (2015)